Home / Market News / $FMC

$FMC news and market catalysts

The 28 most recent market catalysts affecting $FMC, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

28 catalysts 10 high impact 2 bullish 20 bearish Chemicals
Nov 16, 2026 Corporate Catalyst Bearish Impact 65
KeyBanc Downgrades FMC Corporation to Sector Weight
KeyBanc downgraded FMC Corporation's stock rating from Overweight to Sector Weight, indicating a revised, less favorable view of the company's prospects. This matters because analy…
Nov 4, 2026 Corporate Catalyst Bearish Impact 65
UBS Adjusts FMC Corporation Price Target to $6.50
UBS, a major financial institution, has significantly reduced its price target for FMC Corporation's stock from $10 to $6.50. This 35% cut, despite maintaining a 'Neutral' rating, …
Nov 4, 2026 Corporate Catalyst Bullish Impact 55
Citi Maintains Hold Rating on FMC Corporation, Raises Price Target to $7
Citi analyst Patrick Cunningham reaffirmed a 'Hold' rating on FMC Corporation, but notably raised the price target from $6 to $7. This action indicates that while the analyst maint…
Nov 3, 2026 Corporate Catalyst Bearish Impact 75
Analysts Adjust Price Targets for FMC Corporation Following Recent Financial Updates
Following FMC Corporation's Q3 2026 results, several prominent analysts, including Morgan Stanley, BMO Capital Markets, RBC Capital Markets, and Barclays, slashed their price targe…
Nov 2, 2026 Corporate Catalyst Bearish Impact 65
RBC Capital Markets Adjusts FMC Corporation Price Target
RBC Capital Markets reduced its price target for FMC Corporation from $9 to $7 following the company's third-quarter 2026 financial reporting and revised outlook. This indicates th…
Oct 29, 2026 Corporate Catalyst Bearish Impact 95
FMC Corporation Reports Third-Quarter 2026 Results
FMC Corporation reported a Q3 2026 net loss of $2.066 billion, a substantial widening from the previous year, driven by non-cash impairment charges and tax impacts. This severe fin…
Oct 19, 2026 Corporate Catalyst Bearish Impact 65
Citigroup Maintains Neutral on FMC, Lowers Price Target to $6
Citigroup analyst Patrick Cunningham has significantly cut the price target for FMC from $12 to $6, while keeping a Neutral rating. This substantial reduction indicates a more caut…
Oct 16, 2026 Corporate Catalyst Bearish Impact 65
Barclays Maintains Underweight on FMC, Lowers Price Target to $4
Barclays analyst Benjamin Theurer maintained an 'Underweight' rating on FMC and drastically lowered the price target from $9 to $4. This action signals a significantly more bearish…
Oct 16, 2026 Corporate Catalyst Bearish Impact 65
Jefferies Downgrades FMC to Hold, Lowers Price Target to $5
Jefferies analyst Laurence Alexander downgraded FMC from a 'Buy' to a 'Hold' rating and drastically cut the price target from $14 to $5. This action signals a strong negative senti…
Oct 16, 2026 Corporate Catalyst Bearish Impact 85
FMC's Dividend Could Be the Next Casualty As Pesticide Price War Deepens: Analyst
RBC Capital Markets has significantly lowered its price target for FMC from $11 to $9, maintaining a 'Sector Perform' rating, following FMC's sharply reduced third-quarter outlook.…
Oct 16, 2026 Corporate Catalyst Neutral Impact 75
Nike, FMC Corp., Alcoa, Interactive Brokers and Kimberly-Clark: Why These 5 Stocks Are on Investors' Radars Today
The filing details the performance of five individual stocks, each driven by distinct corporate catalysts. FMC Corp. experienced a significant plunge due to a sharply lowered reven…
Oct 15, 2026 Corporate Catalyst Bearish Impact 55
RBC Capital Maintains Sector Perform on FMC, Lowers Price Target to $9
RBC Capital's analyst Arun Viswanathan has maintained a 'Sector Perform' rating on FMC but lowered the price target from $11 to $9. This adjustment suggests a revised valuation exp…
Oct 15, 2026 Corporate Catalyst Bearish Impact 95
FMC Warns of Staggering Losses, Slashes Revenue Outlook
FMC Corporation has issued a dire warning, slashing its Q3 revenue outlook to $65M-$125M and projecting an adjusted EBITDA loss of $565M-$510M, including $625M-$675M in charges. Th…
Oct 15, 2026 Corporate Catalyst Bearish Impact 85
Corteva shares are trading lower amid sympathy with FMC Corporation after that company lowered its Q3 sales guidance and said it expects negative adjusted EBITDA after charges of $625-$675 million from commercial actions.
FMC's drastic downward revision of Q3 sales guidance and the expectation of negative adjusted EBITDA, coupled with substantial commercial action charges, signals significant headwi…
Oct 15, 2026 Corporate Catalyst Bearish Impact 85
FMC Corporation shares are trading lower after the company lowered its Q3 revenue guidance and said commercial actions will result in $625 million to $675 million in charges.
This headline is a significant corporate catalyst for FMC Corporation, directly impacting its financial outlook and stock performance. The lowered revenue guidance indicates weaker…
Oct 15, 2026 Corporate Catalyst Neutral Impact 95
FMC Corp. Now Expects Q3 Revenue To Be $65M-$125M, With Adjusted EBITDA Of Negative $565M To Negative $510M
FMC Corporation has drastically revised its third-quarter 2026 financial outlook, now projecting revenue between $65 million and $125 million and Adjusted EBITDA of negative $565 m…
Oct 13, 2026 Corporate Catalyst Bearish Impact 55
Mizuho Maintains Outperform on FMC, Lowers Price Target to $12
Mizuho's analyst Edlain Rodriguez maintained an 'Outperform' rating on FMC, suggesting a continued belief in the company's underlying strength and potential for growth. However, th…
Oct 5, 2026 Corporate Catalyst Bearish Impact 55
UBS Maintains Neutral on FMC, Lowers Price Target to $10
UBS analyst Joshua Spector reiterated a 'Neutral' rating on FMC but reduced the price target from $12 to $10. This action signals a slightly diminished valuation expectation for FM…
Sep 28, 2026 Corporate Catalyst Bullish Impact 55
FMC Corp. Announces Submission Of Regulatory Dossier For Rimisoxafen To Brazilian Regulatory Authorities
FMC Corporation has submitted a regulatory dossier for its new herbicide, rimisoxafen, to Brazilian authorities. This is a positive development as it signifies progress in bringing…
Sep 11, 2026 Corporate Catalyst Neutral Impact 55
Keybanc Initiates Coverage On FMC with Overweight Rating, Announces Price Target of $16
Keybanc's initiation of coverage on FMC with an Overweight rating and a $16 price target signals a positive outlook from a prominent financial institution. This can be a significan…
Aug 28, 2026 Corporate Catalyst Neutral Impact 65
Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 3% Dividend Yields
The filing highlights recent analyst actions on three materials stocks known for their dividend yields. For FMC, analysts cut price targets following mixed Q2 results, suggesting c…
Jul 31, 2026 Corporate Catalyst Bearish Impact 55
Citigroup Maintains Neutral on FMC, Lowers Price Target to $12
Citigroup analyst Patrick Cunningham has adjusted the price target for FMC, reducing it from $14 to $12. This change, while accompanied by a maintained 'Neutral' rating, suggests a…
Jul 31, 2026 Corporate Catalyst Bearish Impact 55
JP Morgan Maintains Neutral on FMC, Lowers Price Target to $12
JP Morgan analyst Jeffrey Zekauskas maintained a 'Neutral' rating on FMC but reduced the price target from $16 to $12. This action indicates a more pessimistic view on FMC's valuat…
Jul 29, 2026 Corporate Catalyst Neutral Impact 85
FMC Sees Q4 Adj EPS $1.09-$1.33 vs $1.01 Est; Sees Sales $1.060B-$1.200B vs $1.095B Est
FMC's 8-K filing discloses preliminary Q4 adjusted EPS guidance of $1.09-$1.33, which is notably higher than the analyst consensus of $1.01. Similarly, the sales guidance of $1.060…
Jul 29, 2026 Corporate Catalyst Neutral Impact 95
FMC Sees Q3 Adj EPS $0.05-$0.13 vs $0.63 Est; Sees Sales $840.000M-$900.000M vs $950.329M Est
FMC has issued Q3 guidance for adjusted EPS of $0.05-$0.13, dramatically lower than the analyst estimate of $0.63, and sales guidance of $840M-$900M, also below the $950.329M estim…
Jul 29, 2026 Corporate Catalyst Bearish Impact 92
FMC Q2 Adj. EPS $0.26 Beats $0.22 Estimate, Sales $867.000M Miss $905.171M Estimate
FMC's Q2 earnings report presents a mixed picture for investors. While the company managed to beat analyst estimates for adjusted EPS, the more concerning aspect is the substantial…
Jul 29, 2026 Corporate Catalyst Bearish Impact 85
FMC Lowers FY2026 Adj EPS Guidance from $1.63-$1.89 to $1.19-$1.49 vs $1.69 Est; Lowers FY2026 Sales Guidance from $3.600B-$3.800B to $3.500B-$3.700B vs $3.703B Est
FMC announced a substantial reduction in its FY2026 adjusted EPS guidance, moving from a range of $1.63-$1.89 to $1.19-$1.49, significantly below the analyst estimate of $1.69. Con…
Jul 27, 2026 Corporate Catalyst Bearish Impact 55
Barclays Maintains Underweight on FMC, Lowers Price Target to $11
Barclays analyst Benjamin Theurer has maintained an 'Underweight' rating on FMC and lowered the price target from $13 to $11. This analyst downgrade and price target reduction sign…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.